ACE2 and COVID-19: With respect to virus infection, increased ACE2 would likely increase virus uptake, but the virus subsequently reduces ACE2 expression, which could deplete anti-inflammatory functions of ACE2 and thereby worsen outcomes in COVID-19 and IBD.37